← Insider buys
EVMN

Evommune, Inc. · Healthcare

Chief Business & Legal Officer Gregory S. Moss sold $325K of Evommune, Inc.

Sold$324,711
$22.83Price
14,223Shares
−19%Stake

What EVMN did after the filing

Filed Jun 2, copier in the same day
The stock from Tue, Jun 2 open, $21.90
−46.5%
S&P 500, same days
−0.8%

Measured over 30 trading days, to the Jul 16 close.

Traded Thu, May 28. Filed Mon, Jun 1, 8:00 PM ET, after the close. Returns use the Jun 2 open and the Jul 16 close. Not investment advice.